Drugs / Markman Biologics Microsurfaced ADM
last change Jun 2022 re-read 2 minutes ago

Markman Biologics Microsurfaced ADM

Developed for
gingival recession
Investigated by
CellTherX · McGuire Institute

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04614350 Oct 2020 → Feb 2022 gingival recession McGuire Institute Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Markman Biologics Microsurfaced ADM ClinicalTrials.gov intervention name — accepted as the source's own label NCT04614350